Generic Names of Some Trade Name Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs -~ Generic Names of Some Trade Name Drugs - Generic Names of Some...
Some Trade Names of Generic Drugs, THE MERCK MANUAL OF HEALTH & AGING Committed to Providing Medical Information Table of Contents Index Enlarge Text Reset Text Shrink Text -- Buy the Book Learn about participating in clinical trials at this government website: www.clinicaltrials.gov - APPENDIX I - Drug Names: Generic and Trade TOPICS - Introduction -~ Some Trade Names of Generic Drugs-~ Generic Names of Some Trade Name Drugs - Some Trade Names of...
Parkinson's Disease: Movement Disorders: Merck Manual Home Edition Search Recent Searches Index Sections A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Accidents and Injuries Blood Disorders Bone, Joint, and Muscle Disorders Brain, Spinal Cord, and Nerve Disorders Cancer Children's Health Issues Digestive Disorders Disorders of Nutrition and Metabolism Drugs Ear, Nose, and Throat Disorders Eye Disorders Fundamentals Heart and Blood Vessel...
COMT inhibitors for Parkinson's disease - [Medication] - Quest Diagnostics Patient Health Library COMT inhibitors for Parkinson's disease Examples Brand Name Chemical Name Comtan entacapone Stalevo entacapone/levodopa/carbidopa Tasmar tolcapone How It Works Normally when a person takes a dose of levodopa, only a very small portion of the dose actually enters the brain and is changed into dopamine inside the brain.
Improving levodopa-based complications to advance Parkinson's Disease therapies - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Database C C - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
Database E E - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products To purchase documents on-line click on- link attached to selected document!- The fee is $15 per document Documents are delivered by e-mail...
http://www.fda.gov/cder/orange/appendix_a.txt 12, CHLORPHENIRAMINE MALEATE (OTC) CODOXY, ASPIRIN CODRIX, ACETAMINOPHEN COGENTIN, BENZTROPINE MESYLATE COGNEX, TACRINE HYDROCHLORIDE COL-PROBENECID, COLCHICINE COLAZAL, BALSALAZIDE DISODIUM COLBENEMID, COLCHICINE COLD CAPSULE IV, CHLORPHENIRAMINE MALEATE (OTC) COLD CAPSULE V, CHLORPHENIRAMINE MALEATE (OTC) COLESTID, COLESTIPOL HYDROCHLORIDE COLGATE TOTAL, SODIUM FLUORIDE (OTC)...
../99/20796_Comtan_ Food and Drug Administration • Center for Drug Evaluation and Research Title Search Comtan (Entacapone) Tablets Company:--Orion Corporation Application No.:--NDA 20-796 Approval Date:-12/30/1999 Approval Letter(s) - Printed Labeling - Chemistry Review(s) - Pharmacology Review(s)- Part 1 - Part 2 - - Statistical Review(s) - Clinical Pharmacology Biopharmaceutics...
author: USERNAME
Report to the Nation: Drug Review Priority new drug approvals: Alitretinoin Amprenavir (2 dosage forms) Aspirin/extended release-dipyridamole Bexarotene Busulfan Caffeine citrate Cytarabine liposome Dalfopristin/quinupristin Epirubicin hydrochloride Ganirelix acetate Ketotifen fumarate Levonorgestrel Nedocromil sodium Nitric oxide Orlistat Oseltamivir phosphate Pemirolast potassium Pioglitazone hydrochloride...
author: OLIVERN
NMEs Approved in CY 1999 NMEs Approved in Calendar Year 1999 NDA Number Generic Name- Trade Name Dosage Form Applicant - --- Classification- Approval Date - - - - - - - 20-863 Cilostazol Pletal Tablet Otsuka Pharm 1S 01-15-1999 20-886 Alitretinoin Panretin Topical Gel Ligand Pharm 1-PV 02-02-1999 20-955 Sodium Ferric Gluconate Complex Ferrlicit Injectable R&D Labs 1P 02-18-1999 21-007 Amprenavir Agenerase...
author: Elaine Abraham
http://www.fda.gov/cder/foi/label/2003/21485_stalevo_lbl.pdf Overall, following administration of corresponding doses of levodopa, carbidopa and Orion Corporation Combination Tablet 5 Levodopa/ Carbidopa/ Entacapone NDA # 21,485 Revised PI 05- 22- 2003 entacapone as STALEVO or as carbidopa/ levodopa product plus Comtan ® (entacapone) tablets, the mean plasma concentrations of levodopa, carbidopa, and entacapone are comparable...
Microsoft PowerPoint - Frankfurt TE Final HANDOUT.ppt Outperforming the Market Investing in the Future Frankfurt, March 2003 The following information contains certain "Forward- looking Statements" relating to the Company's business, which can be identified by the use of forward- looking terminology such as "will" or "expect", or by discussions of strategy, plans, intentions or potential outcomes.
author: AVOGEL
duplicates:http://www.novartis.com/downloads/rs_frankfurt_te_032003.pdf
G10089_Annual_Rep_FCm Global Performance in the Life Sciences Operational Review 1998 In transplant medicine, one of the key issues is organ rejection
author: SimonT
duplicates:http://www.novartis.com/downloads/opreven98.pdf http://www.novartis.com/downloads/opreven98.pdf
CPMP-2244-98 The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html 26 October 1998 CPMP/ 2244/ ...
author: WELLS
CPMP-2244-98 page 12 CPMP/ 2244/ 98 12/ 17 The approved indication is for the prophylaxis of acute organ rejection in de novo allogeneic renal transplantation. Detailed conditions for the use of this product are described in the Summary of Product Characteristics (SPC) which can be found in the EPAR and is available in ...
author: WELLS
CPMP-2244-98 page 8 CPMP/ 2244/ 98 8/ 17 PRODUCT Brandname COMTAN INN Entacapone Part A/ B B COMPANY ORIGIN Country Finland MARKETING AUTHORISATION HOLDER Name Orion THERAPEUTIC AREA ATC Code N04B X02 Indication Parkinson's disease and end- of- dose motor fluctuations PRESENTATION Pharmaceutical form Film coated ...
author: WELLS
CPMP-2244-98 page 2 CPMP/ 2244/ 98 2/ 17 Roche will communicate amended information to EU health professionals without delay in all EU languages and will submit as of November monthly reports to the EMEA/ CPMP. · One positive Opinion by consensus following the annual re- assessment for a Medicinal Product (Part A), an ...
author: WELLS
cpmp_pr_2572_98 The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html 24 November 1998 CPMP/ 2572/ ...
author: WELLS
cpmp_pr_2572_98 page 2 CPMP/ 2572/ 1998 2/ 6 One positive Opinion was adopted by consensus relating to one Application in accordance with Annex II (an additional pharmaceutical form) for an already Centrally Authorised Medicinal Product containing an immuno- suppressive agent (Part B), indicated for prophylaxis of ...
author: WELLS
em_pr_39582_98 The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html Immediate release London, ...
author: WELLS
em_pr_39582_98 page 2 EMEA/ 39582/ 98 2/ 2 The following provisional changes have been made to the prescribing information: · Entacapone is not recommended for patients with a previous history of NMS and/ or nontraumatic rhabdomyolysis. · Rhabdomyolysis secondary to severe dyskinesias or NMS has also been observed ...
author: WELLS
em_pr_39582_98 page 1 The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit 7 Westferry Circus, Canary Wharf, London E14 4HB, UK Switchboard: (+ 44- 171) 418 8400 Fax: (+ 44- 171) 418 8551 E_ Mail: mail@ emea. eudra. org http:// www. eudra. org/ emea. html Immediate release London, ...
author: WELLS
CDER 1999 Report to the Nation 1999 new molecular entities: Alitretinoin (Panretin) Aminolevulinic acid hydrochloride (Levulan Kerastick) Amprenavir (Agenerase) Bexarotene (Targretin) Cilostazol (Pletal) Dalfopristin/ quinupristin (Synercid) Dexmedetomidine hydrochloride (Precedex) Dofetilide (Tikosyn) Doxercalciferol (Hectorol) Entacapone (Comtan) Epirubicin hydrochloride (Ellence) Exemestane ...
author: Center for Drug Evaluation and Research
subject: Improving Public Health Through Human Drugs
CDER 1999 Report to the Nation page 12
author: Center for Drug Evaluation and Research
subject: Improving Public Health Through Human Drugs
